Blonanserin Orally Disintegrating Tablets( Lp Pharma)

布南色林口崩片(力品药业)

Report date: 2026/03/31 15:23:08

Base Information

Drug NameBlonanserin Orally Disintegrating Tablets( Lp Pharma)
Drug Alias Nameblonanserina布南瑟林blonanserinum布蓝色林布南色林口崩片(2.2类改良型)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsDopamine D2 receptor antagonists
TargetsSerotonin 2a (5-HT2a) receptorDopamine D2 receptor
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSchizophrenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A